JOINT FILING AGREEMENT
Exhibit 1
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Achieve Life Sciences, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement.
Dated: November 21, 2022
Dialectic Capital Management LP
Dialectic Partners, LLC
Dialectic Life Sciences SPV LLC
Dialectic LS Manager LLC
Xxxx Xxxxxxxxx
| By: | /s/ Xxxx Xxxxxxxxx | |
| Name: Xxxx Xxxxxxxxx | ||
| Title: Authorized Signatory | ||
Page 12 of 12 Pages
